Invivyd Stock Surges on Positive VYD222 Clinical Trial Results
Invivyd Inc, a pioneering biopharmaceutical company dedicated to safeguarding vulnerable populations from severe viral infectious diseases, unveiled promising preliminary findings today from the ongoing CANOPY